Related Experiment Video
Updated: Aug 11, 2026

08:40
Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
Published on: February 28, 2021
Positron emission tomography in juvenile Alexander disease
Y Sawaishi1, J Hatazawa, N Ochi
1Department of Pediatrics, Akita University School of Medicine, Japan. sawaishi@med.akita-u.ac.jp
Journal of the Neurological Sciences
|August 18, 1999
Summary
Juvenile Alexander disease was diagnosed in a boy with cervical kyphosis, confirmed by MRI and elevated proteins in cerebrospinal fluid. Brain imaging revealed white matter hypometabolism, sparing the gray matter.
Area of Science:
- Neurology
- Neurodegenerative Diseases
- Medical Imaging
Background:
- Juvenile Alexander disease is a rare, fatal leukodystrophy.
- Cervical kyphosis can be an early sign.
- Diagnosis relies on clinical, imaging, and biochemical markers.
Observation:
- A 13-year-old male presented with cervical kyphosis and was evaluated for neurological disorders.
- Cerebrospinal fluid analysis revealed elevated levels of alphaB-crystallin and heat shock protein 27.
- Magnetic resonance imaging (MRI) indicated characteristic leukodystrophy in the brain's white matter.
Findings:
- The patient was diagnosed with juvenile Alexander disease based on clinical presentation, MRI findings, and biomarker elevation.
- Positron emission tomography (PET) using 18F-fluorodeoxyglucose (FDG) demonstrated hypometabolism in the frontal white matter.
- Crucially, the adjacent gray matter exhibited normal glucose metabolism, suggesting selective white matter vulnerability.
Implications:
- This case highlights the utility of combining MRI, cerebrospinal fluid biomarkers, and FDG-PET for diagnosing juvenile Alexander disease.
- The preserved gray matter metabolism despite white matter involvement offers insights into the disease's pathophysiology.
- Further research into the selective vulnerability of white matter in Alexander disease is warranted.
Related Concept Videos
Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET

